BATTAGLIA, Michele
 Distribuzione geografica
Continente #
NA - Nord America 15.933
EU - Europa 5.984
AS - Asia 1.646
SA - Sud America 39
Continente sconosciuto - Info sul continente non disponibili 9
OC - Oceania 7
AF - Africa 1
Totale 23.619
Nazione #
US - Stati Uniti d'America 15.911
IT - Italia 2.540
CN - Cina 1.350
SE - Svezia 942
UA - Ucraina 708
DE - Germania 619
FI - Finlandia 400
GB - Regno Unito 253
FR - Francia 242
SG - Singapore 96
BE - Belgio 81
VN - Vietnam 73
IE - Irlanda 67
IN - India 66
RU - Federazione Russa 32
CH - Svizzera 27
IR - Iran 22
CA - Canada 16
BR - Brasile 13
RO - Romania 10
AR - Argentina 9
CZ - Repubblica Ceca 9
EU - Europa 8
KR - Corea 8
ES - Italia 7
NL - Olanda 7
AU - Australia 6
CO - Colombia 6
JP - Giappone 6
PT - Portogallo 6
PL - Polonia 5
VE - Venezuela 5
BD - Bangladesh 4
HR - Croazia 4
LU - Lussemburgo 4
MX - Messico 4
TR - Turchia 4
BG - Bulgaria 3
CL - Cile 3
DK - Danimarca 3
GR - Grecia 3
KZ - Kazakistan 3
TH - Thailandia 3
EE - Estonia 2
HK - Hong Kong 2
HU - Ungheria 2
IL - Israele 2
RS - Serbia 2
TW - Taiwan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AE - Emirati Arabi Uniti 1
AT - Austria 1
BO - Bolivia 1
BT - Bhutan 1
DO - Repubblica Dominicana 1
EC - Ecuador 1
EG - Egitto 1
LT - Lituania 1
MD - Moldavia 1
MK - Macedonia 1
MT - Malta 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PE - Perù 1
PK - Pakistan 1
PR - Porto Rico 1
SA - Arabia Saudita 1
UZ - Uzbekistan 1
Totale 23.619
Città #
Fairfield 2.034
Chandler 1.721
Jacksonville 1.615
Woodbridge 1.443
Ashburn 1.020
Houston 868
Seattle 849
Cambridge 769
Wilmington 707
Nyköping 663
Ann Arbor 638
Lawrence 414
Roxbury 414
Nanjing 389
New York 290
Des Moines 275
Beijing 271
Bari 227
Princeton 176
Boardman 144
Rome 135
Milan 113
Shenyang 106
Nanchang 101
Inglewood 96
Hebei 95
San Diego 92
Brussels 77
Dearborn 74
Dong Ket 73
Jiaxing 72
Brooklyn 66
Dublin 63
Tianjin 61
Changsha 56
Redwood City 56
Singapore 54
London 53
Paris 49
Naples 45
Pune 39
Bologna 33
Helsinki 28
Palermo 28
Falls Church 26
Florence 26
Los Angeles 26
Guangzhou 24
Turin 23
San Mateo 22
Augusta 21
Washington 21
Leawood 20
Hefei 16
Monmouth Junction 15
Torino 15
Auburn Hills 14
Norwalk 14
Brescia 12
Modugno 12
Munich 12
Mola Di Bari 11
Toronto 11
Jinan 10
Kunming 10
Napoli 10
Ningbo 10
Verona 10
Ardabil 9
Chicago 9
Dallas 9
Lodi 9
New Bedfont 9
Shanghai 9
Tappahannock 9
Taranto 9
Catania 8
Mumbai 8
Bitonto 7
Hounslow 7
Perugia 7
Rimini 7
Trani 7
Wuhan 7
Zhengzhou 7
Altamura 6
Como 6
Ferentino 6
Frankfurt am Main 6
Hangzhou 6
Kilburn 6
Mcallen 6
Monopoli 6
Padova 6
Prescot 6
Taizhou 6
Trento 6
Acton 5
Adelfia 5
Bergamo 5
Totale 17.207
Nome #
L’INFILTRAZIONE PERINEURALE E LA POSITIVITA’ DEI MARGINI CHIRURGICI NELLA PROGNOSI DEI PAZIENTI CON CARCINOMA PROSTATICO SOTTOPOSTI A PROSTATECTOMIA RADICALE. 1.448
ACCESSO LOMBOTOMICO VS ACCESSO TRANSPERITONEALE NELLA CHIRURGIA DEL CARCINOMA RENALE. RISULTATI PRELIMINARI DI UNO STUDIO RANDOMIZZATO. 550
LA FISTOLA CAVERNO-SPONGIOSA SECONDO WINTER NEL TRATTAMENTO DEL PRIAPISMO IDIOPATICO. 157
miR-29b and miR-198 overexpression in CD8+ T cells of renal cell carcinoma patients down-modulates JAK3 and MCL-1 leading to immune dysfunction 156
A 1-year maintenance after early adjuvant intravesical chemotherapy has a limited efficacy in preventing recurrence of intermediate risk non-muscle-invasive bladder cancer. 144
Serum sarcosine increases the accuracy of prostate cancer detection in patients with total serum PSA less than 4.0 ng/ml. 134
Metabolomic profile of glycolysis and the pentose phosphate pathway identifies the central role of glucose-6-phosphate dehydrogenase in clear cell-renal cell carcinoma. 132
Loss of STK11 expression is an early event in prostate carcinogenesis and predicts therapeutic response to targeted therapy against MAPK/p38. 132
Isolation and characterization of cancer stem cells in renal cell carcinoma. 126
Complement Modulation of Anti-Aging Factor Klotho in Ischemia/Reperfusion Injury and Delayed Graft Function 126
Increased Expression of the Autocrine Motility Factor is Associated With Poor Prognosis in Patients With Clear Cell-Renal Cell Carcinoma 124
Capillary hemangioma of the scrotum mimicking an epididymal tumor: case report. 122
Addition of sirolimus to cyclosporine delays the recovery from delayed graft function but does not affect 1-year graft function 121
LE ANASTOMOSI URETERO-INTESTINALI: CONDOTTO ILEALE CON URETERO - ILEOANASTOMOSI SECONDO WALLACE. 120
null 119
ANGIOMIOLIPOMA CALCIFICO DEL RENE. 117
Renal progenitor cells revert LPS-induced endothelial-to-mesenchymal transition by secreting CXCL6, SAA4, and BPIFA2 antiseptic peptides 115
Activation of the kynurenine pathway predicts poor outcome in patients with clear cell renal cell carcinoma 115
Bilateral tumors of the testis in 21-alpha hydroxylase deficiency without adrenal hyperplasia 113
Role of imaging and biopsy to assess local recurrence after definitive treatment for prostate carcinoma 112
Integrated multi-omics characterization reveals a distinctive metabolic signature and the role of NDUFA4L2 in promoting angiogenesis, chemoresistance, and mitochondrial dysfunction in clear cell renal cell carcinoma 112
Urinary RKIP/p-RKIP is a potential diagnostic and prognostic marker of clear cell renal cell carcinoma 111
Complement-dependent NADPH oxidase enzyme activation in renal ischemia/reperfusion injury. 108
Androgen deprivation therapy affects BCL-2 expression in human prostate cancer 108
Allograft nephrectomy: Intracapsular vs extracapsular tecnique 107
Rapamycin for treatment of chronic allograft nephropathy in renal transplant patients 107
Clinical management of a unique case of PNET of the uterus during pregnancy, and review of the literature 107
Cyclosporin exposure correlates with 1 year graft function and histological damage in renal transplanted patients 105
UROCITOLOGIA E COLPOCITOLOGIA IN CLIMATERIO E NELLA SENILITA' 103
A single-center cohort study to define the role of pretransplant biopsy score in the long-term outcome of kidney transplantation. 103
Lethal somatostatin analog-induced acute necrotizing pancreatitis in a patient with hormone-refractory prostate cancer 103
Renal Cell Carcinoma: A Study through NMR-Based Metabolomics Combined with Transcriptomics 103
T helper 1, 2 and 17 cell subsets in renal transplant patients with delayed graft function 102
Spontaneous rupture of an ileal neobladder 6 years after construction 101
VHL gene alterations in Italian patients with isolated renal cell carcinomas 100
Prednisone plus gefitinib versus prednisone plus placebo in the treatment of hormone-refractory prostate cancer: a randomized phase II trial 100
Complement component C5a induces aberrant epigenetic modifications in renal tubular epithelial cells accelerating senescence by Wnt4/βcatenin signaling after ischemia/reperfusion injury 100
Repair of vaginal prolapse following penoscrotal flap vaginoplasty in a male-to-female transsexual 99
Impact of donor-recipient gender on kidney graft and patient survival: short- and long-term outcomes. 98
Dysfunctional DC subsets in RCC patients: Ex vivo correction to yield an effective anti-cancer vaccine 98
Soluble Serum αklotho Is a Potential Predictive Marker of Disease Progression in Clear Cell Renal Cell Carcinoma 98
Incidental prostatic cancer: repeat TURP or biopsy? 98
Early withdrawal of cyclosporine A improves 1-year kidney graft structure and function in sirolimus-treated patients 98
An increased body mass index is associated with a worse prognosis in patients administered BCG immunotherapy for T1 bladder cancer 98
Experience of percutaneous access under ultrasound guidance in renal transplant patients with allograft lithiasis 96
BCG septicemia after radical cystectomy: a rare postoperative complication following BCG therapy 95
GOSERELIN ACETATE WITH OR WITHOUT FLUTAMIDE IN THE TREATMENT OF PATIENTS WITH LOCALLY ADVANCED OR METASTATIC PROSTATE-CANCER 94
Advanced age is not an exclusion criterion for kidney transplantation. 94
Genome-wide analysis of differentially expressed genes and splicing isoforms in clear cell renal cell carcinoma. 94
Recurrent urinary tract infections in kidney transplant recipients during the first-year influence long-term graft function: a single-center retrospective cohort study 94
Microvascular density, macrophages, and mast cells in human clear cell renal carcinoma with and without bevacizumab treatment 92
Kidney transplants from infected donors: Our experience 91
Penile prosthesis: what should we do about complications? 91
Evaluation of tamoxifen and anastrozole in the prevention of gynecomastia and breast pain induced by bicalutamide monotherapy of prostate cancer 90
Pre-existing Type 2 Diabetes Mellitus Is an Independent Risk Factor for Mortality and Progression in Patients With Renal Cell Carcinoma. 90
Adjuvant hormone therapy after radical prostatectomy: Indications and results 89
Therapeutic targeting of classical and lectin pathways of complement protects from ischemia-reperfusion-induced renal damage 89
null 89
Adherence to EAU guidelines on penile cancer translates into better outcomes: a multicenter international study 89
Complement activation during ischemia/reperfusion injury induces pericyte-to-myofibroblast transdifferentiation regulating peritubular capillary Lumen Reduction Through pERK Signaling 88
Interleukin-27 is a potential marker for the onset of post-transplant malignancies 87
Allograft nephrectomy: what is the best surgical technique? 87
True mycotic arteritis by Candida albicans in 2 kidney transplant recipients from the same donor 86
Penile prosthesis implant: when, what and how 86
null 86
null 86
Low serum total testosterone level as a predictor of upstaging and upgrading in low-risk prostate cancer patients meeting the inclusion criteria for active surveillance 86
Medical and surgical complications after kidney transplantation from "suboptimal donors": One centre's experience 85
Middle and long-term outcomes of dual kidney transplant: a multicenter experience 85
Prospective randomized trial comparing high lumbotomic with laparotomic access in renal cell carcinoma surgery 85
Altered p53 and pRb expression is predictive of response to BCG treatment in T1G3 bladder cancer. Anticancer Res. 2009 Oct;29(10):4201-4. PubMed PMID: 19846973 84
Current insights in renal cell cancer pathology 84
Predictive value of resistive index in graft survival after kidney transplant. 83
The three-gene signature in urinary extracellular vesicles from patients with clear cell renal cell carcinoma 83
Spondin-2, a Secreted Extracellular Matrix Protein, Is a Novel Diagnostic Biomarker for Prostate Cancer. 83
Endothelial-to-Mesenchymal Transition (EndMT) in Swine Renal Ischemia Reperfusion (I/R) Injury Is Mediated by Complement and AKT Pathway 82
ATTEMPT TO CORRECT IMMUNE DEFICITS IN PATIENTS WITH CHRONIC URINARY-TRACT INFECTION BY ADMINISTRATION OF A THYMIC EXTRACT 82
Influence of bicalutamide with or without tamoxifen or anastrozole on insulin-like growth factor 1 and binding proteins in prostate cancer patients 81
Establishment and characterization of a highly immunogenic human renal carcinoma cell line 81
Systemic Inflammatory Markers and Oncologic Outcomes in Patients with High-risk Non–muscle-invasive Urothelial Bladder Cancer 81
Adherence to the EAU guidelines on Penile Cancer Treatment: European, multicentre, retrospective study 81
Ischemia-reperfusion induces glomerular and tubular activation of proinflammatory and antiapoptotic pathways: differential modulation by rapamycin 81
Penile prosthesis implant for primary erectile dysfunction in patient with Klippel-Trenaunay syndrome complicated by consumptive coagulopathy: A case report 81
ORAL PROPHYLAXIS WITH FOSFOMYCIN TROMETAMOL IN TRANSURETHRAL PROSTATECTOMY AND UROLOGICAL MANEUVERS - LITERATURE-REVIEW AND PERSONAL-EXPERIENCE 80
Optimization of analytical and pre-analytical conditions for MALDI-TOF-MS human urine protein profiles 80
Patient and partner satisfaction after AMS inflatable penile prosthesis implant 79
A challenging surgical approach to locally advanced primary urethral carcinoma: A case report and literature review 79
Serum sarcosine is a risk factor for progression and survival in patients with metastatic castration-resistant prostate cancer. 79
SERUM SARCOSINE INCREASES THE ACCURACY OF PROSTATE CANCER DETECTION IN LOW RANGE PSA 79
Single-step surgical tretment of adrenal pheochromocytoma and medullary thyroid carcinoma in Sipple's Syndrome 79
Androgen deprivation therapy regulation of beta 1C integrin expression in prostate cancer 78
Double J stent with antireflux device in the prevention of short-term urological complications after cadaveric kidney transplantation: single-center prospective randomized study 77
Extended criteria donor kidney transplantation: comparative outcome analysis between single versus double kidney transplantation at 5 years 77
Statin use and survival in patients with metastatic castrationresistant prostate cancer treated with abiraterone or enzalutamide after docetaxel failure: The international retrospective observational STABEN study 76
Experience with cyclosporine: approaching the therapeutic window for C2 levels in maintenance kidney transplant recipients 75
Emerging urinary markers of renal injury in obstructive nephropathy. 74
null 74
Lymph node staging in early prostatic carcinoma with radioguided sentinel node biopsy 74
Testicular granulosa cell tumor of adult type: a new case and a review of the literature 73
Bicalutamide monotherapy versus flutamide plus goserelin in prostate cancer: Updated results of a multicentric trial 73
Totale 11.447
Categoria #
all - tutte 97.954
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 97.954


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20206.261 1.085 396 150 431 740 382 699 515 740 343 577 203
2020/20214.292 391 288 316 269 525 158 390 285 408 524 411 327
2021/20222.909 171 425 52 128 159 181 124 169 168 212 464 656
2022/20234.676 708 418 248 462 538 618 94 508 773 55 139 115
2023/20241.713 201 317 110 112 124 451 57 99 23 51 33 135
2024/2025129 129 0 0 0 0 0 0 0 0 0 0 0
Totale 24.228